ad image

Market Analysis

1 / 1
Biotech Funding Ups and Downs
Nice Insight Reports

Biotech Funding Ups and Downs

April Stanley, MS MBA

Nice Insight

PAO-04-24-NI-01Apr 02, 2024
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
FDA New Drug Approvals

Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-03-23-NI-03Mar 07, 2023
State of the Cell and Gene Therapy Market
Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

PAO-10-022-NI-01Oct 11, 2022
1 / 1